Filing Flows › HCW Biologics (HCWB) › Stock forecast & fair value
HCW Biologics (HCWB) stock forecast and price target
HCW Biologics (HCWB) trades at $1.02. One analyst's price target is $48.00 (47×).
HCW Biologics' latest quarter
HCW Biologics, Q2 2026: revenue $136K (21× year over year), net loss $5.2M, operating cash flow −$4.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for HCWB stock?
One analyst's 12-month target is $48.00, 47× from $1.02. The average rating is none.
Does HCW Biologics usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is HCWB stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.